Xbrane Biopharma AB Net Asset Momentum
Xbrane Biopharma AB net asset momentum. Xbrane Biopharma AB (XBRANE) recorded a net asset momentum of 168.8% as of December 2025, with net assets of Skr560.65 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore capital reinvestment ratio of Xbrane Biopharma AB to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Xbrane Biopharma AB (2012–2025)
Net asset momentum of Xbrane Biopharma AB from 2012 to 2025. This chart tracks Xbrane Biopharma AB's year-over-year net asset growth across 14 annual reporting periods from 2012 to 2025. The most recent momentum reading is +168.8%, with net assets of Skr560.65 Million SEK as of December 2025. See Xbrane Biopharma AB net assets for net asset value and shareholders' equity analysis.
Xbrane Biopharma AB Net Asset Momentum by Year (2012–2025)
Xbrane Biopharma AB net asset momentum by year from 2012 to 2025. The table below shows the complete annual net asset history for Xbrane Biopharma AB from 2012 to 2025, covering 14 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of Xbrane Biopharma AB.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Skr560.65 Million | Skr671.62 Million | Skr110.97 Million | ▲ +168.8% |
| 2024 | Skr208.54 Million | Skr842.43 Million | Skr633.89 Million | ▲ +21.7% |
| 2023 | Skr171.34 Million | Skr653.51 Million | Skr482.17 Million | ▼ -59.7% |
| 2022 | Skr424.89 Million | Skr690.51 Million | Skr265.63 Million | ▼ -1.6% |
| 2021 | Skr431.74 Million | Skr688.43 Million | Skr256.69 Million | ▲ +67.5% |
| 2020 | Skr257.71 Million | Skr463.76 Million | Skr206.06 Million | ▲ +39.8% |
| 2019 | Skr184.32 Million | Skr338.94 Million | Skr154.62 Million | ▲ +121.9% |
| 2018 | Skr83.07 Million | Skr252.88 Million | Skr169.81 Million | ▼ -6.0% |
| 2017 | Skr88.41 Million | Skr110.96 Million | Skr22.55 Million | ▼ -17.6% |
| 2016 | Skr107.30 Million | Skr118.11 Million | Skr10.81 Million | ▲ +125.9% |
| 2015 | Skr47.51 Million | Skr75.33 Million | Skr27.82 Million | ▲ +654.4% |
| 2014 | Skr6.30 Million | Skr6.69 Million | Skr390.70K | ▼ -27.5% |
| 2013 | Skr8.69 Million | Skr9.20 Million | Skr505.44K | ▲ +9762.8% |
| 2012 | Skr88.11K | Skr657.01K | Skr568.90K | — |